Wakix

Active Ingredient(s): Pitolisant Hydrochloride
FDA Approved: * August 14, 2019
Pharm Company: * BIOPROJET PHARMA
Category: Narcolepsy

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Wakix Overview

Pitolisant, sold under the brand name Wakix, is a potent and highly selective histamine 3 (H) receptor antagonist/inverse agonist, representing the first commercially available medication in its class. Pitolisant enhances the activity of histaminergic neurons in the brain that function to improve a person's wakefulness and decrease the number of cataplexy attacks in people that suffer from narcolepsy.[1] History Pitolisant was developed by Jean-Charles Schwartz, Walter Schu...

Read more Wakix Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Pitolisant

Recent Wakix Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Wakix: (2 results)

Sorted by National Drug Code

• 72028-045 Wakix 4.45 mg Oral Tablet, Film Coated by Harmony Biosciences, LLC
• 72028-178 Wakix 17.8 mg Oral Tablet, Film Coated by Harmony Biosciences, LLC

Other drugs which contain Pitolisant Hydrochloride or a similar ingredient: (1 result)

• PITOLISANT